Issue 106 • May 2021

Human challenge trials

Drug dispensing goes digital

The future of regenerative medicine

Antibiotic Adjacent

With the threat of antimicrobial resistance looming, researchers are exploring alternative treatment options

02/23/2024 22:36:39

04/22/2021 00:00:00

Go to article: Home | Antibiotic Adjacent Go to article: In this issue Go to article: Contents Go to article: SHL Company Insight Go to article: SHL Medical Go to article: Tive Go to article: Controlant Company Insight Go to article: Controlant Go to article: Briefing Go to article: Industry news Go to article: The pharma industry briefing Go to article: Covid-19 executive briefing by GlobalData Go to article: Mimotopes Company Insight Go to article: Mimotopes Go to article: L.B. Bohle Maschinen Go to article: L.B Bohle Company Insight Go to article: ACG Worldwide Go to article: Comment Go to article: HPV infections drop due to widespread vaccination Go to article: Europe reports the highest prevalence of chronic cough across the 7MM Go to article: How could vaccine hesitancy affect the prevalence of hearing disorders?Go to article: Datwyler Company Insight Go to article: Datwyler Go to article: RegPak Go to article: Pfeiffer Go to article: In Depth Go to article: Antibiotic adjacent: the alternatives tackling AMR Go to article: Regenerative medicine: ready for the big leagues? Go to article: Human challenge trials: pandemic exit strategy or ethical nightmare?Go to article: Drug dispensing goes digital Go to article: Could this Novartis initiative finally cure sickle cell disease?Go to article: Centessa Pharmaceuticals: forging a new path for pharma R&D Go to article: Biomax Company Insight Go to article: Biomax Go to article: Duoject Go to article: Duoject Company Insight Go to article: In Data Go to article: Deals analysis Go to article: The pharma industry key list Go to article: Global markets and indices Go to article: Macro-economic indicators Go to article: Macro-economic indicators (page 2)Go to article: The Solubility Company - Company Insight Go to article: The Solubility company Go to article: Myonex Go to article: Baxter Go to article: Events Go to article: Next issue